Skip to main content
Erschienen in: Indian Journal of Gastroenterology 6/2012

01.12.2012 | Editorial

Inflammatory bowel disease: the Indian augury

verfasst von: Vineet Ahuja, Rakesh K Tandon

Erschienen in: Indian Journal of Gastroenterology | Ausgabe 6/2012

Einloggen, um Zugang zu erhalten

Excerpt

A little boy accompanied by his father was taken to a museum of diseases. His father gloated upon mankind’s successes in alleviating diseases. The first window showed smallpox and its demise, the second window showed plague and its extermination, and the third window showed malaria and its systematic decimation. The little boy’s faith in dominance of medical science soared and he started getting convinced in the infallibility of man as he mounted the steps to the second floor of the museum. The second floor was damp and squidgy and so became the little boy’s enthusiasm when he saw conquests being replaced by new scourges, a whole row of emerging diseases: diabetes, multiple sclerosis, and celiac disease. Spontaneously, he remarked, “The disease wagon appears to have a mind of its own and keeps on replacing conquered diseases with a new or complex one. As if the disease wagon is leading medical scientists on an ever ongoing merry-go-round. Is the field of medicine moving in circles and trying to catch its own tail?” His father, a wise seasoned soul, assuaged his crestfallen son and explained “Predicting and controlling diseases ultimately requires an intuitive appreciation of biocomplexity—the elaborate interrelationships between biological systems (including human social systems) and their physical environments and until we do it the circle will move on.” This is precisely the most significant message the emergence of inflammatory bowel disease (IBD) in India augurs for the medical community. The initiative of Indian Society of Gastroenterology (ISG) Task Force and the ensuing survey is a laudatory effort which has propelled awareness of IBD as a disease from background to the fore. …
Literatur
2.
Zurück zum Zitat Bach J-F. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med. 2002;347:911–20.PubMedCrossRef Bach J-F. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med. 2002;347:911–20.PubMedCrossRef
3.
Zurück zum Zitat Pugazhendhi S, Sahu MK, Subramanian V, Pulimood A, Ramakrishna BS. Environmental factors associated with Crohn’s disease in India. Indian J Gastroenterol. 2011;30:264–9.PubMedCrossRef Pugazhendhi S, Sahu MK, Subramanian V, Pulimood A, Ramakrishna BS. Environmental factors associated with Crohn’s disease in India. Indian J Gastroenterol. 2011;30:264–9.PubMedCrossRef
5.
Zurück zum Zitat Schultz M, Butt AG. Is the north to south gradient in inflammatory bowel disease a global phenomenon? Expert Rev Gastroenterol Hepatol. 2012;6:445–7.PubMedCrossRef Schultz M, Butt AG. Is the north to south gradient in inflammatory bowel disease a global phenomenon? Expert Rev Gastroenterol Hepatol. 2012;6:445–7.PubMedCrossRef
6.
Zurück zum Zitat Shivananda S, Lennard-Jones J, Logan R, et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut. 1996;39:690–7.PubMedCrossRef Shivananda S, Lennard-Jones J, Logan R, et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut. 1996;39:690–7.PubMedCrossRef
7.
Zurück zum Zitat Khalili H, Huang ES, Ananthakrishnan AN, et al. Geographical variation and incidence of inflammatory bowel disease among US women. Gut. 2012. doi:10.1136/gutjnl-2011-301574. Epub ahead of print. Khalili H, Huang ES, Ananthakrishnan AN, et al. Geographical variation and incidence of inflammatory bowel disease among US women. Gut. 2012. doi:10.​1136/​gutjnl-2011-301574. Epub ahead of print.
8.
Zurück zum Zitat Nerich V, Jantchou P, Boutron-Ruault MC, et al. Low exposure to sunlight is a risk factor for Crohn’s disease. Aliment Pharmacol Ther. 2011;33:940–5.PubMedCrossRef Nerich V, Jantchou P, Boutron-Ruault MC, et al. Low exposure to sunlight is a risk factor for Crohn’s disease. Aliment Pharmacol Ther. 2011;33:940–5.PubMedCrossRef
9.
Zurück zum Zitat Ahuja V, Tandon RK. Inflammatory bowel disease in the Asia-Pacific area; a comparison with developed countries and regional differences. J Dig Dis. 2010;11:134–47.PubMedCrossRef Ahuja V, Tandon RK. Inflammatory bowel disease in the Asia-Pacific area; a comparison with developed countries and regional differences. J Dig Dis. 2010;11:134–47.PubMedCrossRef
10.
Zurück zum Zitat Chouraki V, Savoye G, Dauchet L, et al. The changing pattern of Crohn’s disease incidence in northern France: a continuing increase in the 10- to 19-year-old age bracket (1988–2007). Aliment Pharmacol Ther. 2011;33:1133–42.PubMedCrossRef Chouraki V, Savoye G, Dauchet L, et al. The changing pattern of Crohn’s disease incidence in northern France: a continuing increase in the 10- to 19-year-old age bracket (1988–2007). Aliment Pharmacol Ther. 2011;33:1133–42.PubMedCrossRef
11.
Zurück zum Zitat Latour P, Louis E, Belaiche J. Incidence of inflammatory bowel disease in the area of Liege: a 3 years prospective study (1993–1996). Acta Gastroenterol Belg. 1998;61:410–3.PubMed Latour P, Louis E, Belaiche J. Incidence of inflammatory bowel disease in the area of Liege: a 3 years prospective study (1993–1996). Acta Gastroenterol Belg. 1998;61:410–3.PubMed
12.
Zurück zum Zitat Hellers G. Crohn’s disease in Stockholm county 1955–74. A study of epidemiology, result of surgical treatments and long term prognosis. Scand J Gastroenterol. 1979;7:401–5. Hellers G. Crohn’s disease in Stockholm county 1955–74. A study of epidemiology, result of surgical treatments and long term prognosis. Scand J Gastroenterol. 1979;7:401–5.
13.
Zurück zum Zitat Bernstein CN, Blanchard JF, Rawsthorne P, et al. Epidemiology of Crohn’s disease and UC in a central Canadian province: a population-based study. Am J Epidemiol. 1999;149:916–24.PubMedCrossRef Bernstein CN, Blanchard JF, Rawsthorne P, et al. Epidemiology of Crohn’s disease and UC in a central Canadian province: a population-based study. Am J Epidemiol. 1999;149:916–24.PubMedCrossRef
14.
Zurück zum Zitat Stowe SP, Redmond SR, Stormont JM, et al. An epidemiologic study of inflammatory bowel disease in Rochester, New York. Hospital incidence. Gastroenterology. 1990;98:104–10.PubMed Stowe SP, Redmond SR, Stormont JM, et al. An epidemiologic study of inflammatory bowel disease in Rochester, New York. Hospital incidence. Gastroenterology. 1990;98:104–10.PubMed
15.
Zurück zum Zitat Thomas GA, Millar-Jones D, Rhodes J, et al. Incidence of Crohn’s disease in Cardiff over 60 years: 1986–1990 an update. Eur J Gastroenterol Hepatol. 1995;7:401–5.PubMed Thomas GA, Millar-Jones D, Rhodes J, et al. Incidence of Crohn’s disease in Cardiff over 60 years: 1986–1990 an update. Eur J Gastroenterol Hepatol. 1995;7:401–5.PubMed
16.
Zurück zum Zitat Daiss W, Scheurlen M, Malchow H. Epidemiology of inflammatory bowel disease in the county of Tubingen (West Germany). Scand J Gastroenterol. 1989;24 suppl 170:39.CrossRef Daiss W, Scheurlen M, Malchow H. Epidemiology of inflammatory bowel disease in the county of Tubingen (West Germany). Scand J Gastroenterol. 1989;24 suppl 170:39.CrossRef
17.
Zurück zum Zitat Molinié F, Gower-Rousseau C, Yzet T, et al. Opposite evolution in incidence of Crohn’s disease and ulcerative colitis in Northern France (1988–1999). Gut. 2004;53:843–8.PubMedCrossRef Molinié F, Gower-Rousseau C, Yzet T, et al. Opposite evolution in incidence of Crohn’s disease and ulcerative colitis in Northern France (1988–1999). Gut. 2004;53:843–8.PubMedCrossRef
18.
Zurück zum Zitat Rogler G, Bernstein CN, Sood A, et al. Role of biological therapy for inflammatory bowel disease in developing countries. Gut. 2012;61:706–12.PubMedCrossRef Rogler G, Bernstein CN, Sood A, et al. Role of biological therapy for inflammatory bowel disease in developing countries. Gut. 2012;61:706–12.PubMedCrossRef
Metadaten
Titel
Inflammatory bowel disease: the Indian augury
verfasst von
Vineet Ahuja
Rakesh K Tandon
Publikationsdatum
01.12.2012
Verlag
Springer-Verlag
Erschienen in
Indian Journal of Gastroenterology / Ausgabe 6/2012
Print ISSN: 0254-8860
Elektronische ISSN: 0975-0711
DOI
https://doi.org/10.1007/s12664-012-0272-3

Weitere Artikel der Ausgabe 6/2012

Indian Journal of Gastroenterology 6/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.